Perrigo CoMEX:PRGON 44 PB Ratio is 1.71 as of Jun. 25, 2026, which is 60% above its 10-year median of 1.07. GuruFocus rates MEX:PRGON with a GF Score™ of 44/100 and a GF Value™ of MXN1,468.70. The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Perrigo Co ranks better than 90.46% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Perrigo Co's share price is MXN557.52. Perrigo Co's Book Value per Share for the quarter that ended in Mar. 2026 was MXN326.29. Hence, Perrigo Co's PB Ratio of today is 1.71.
The historical rank and industry rank for Perrigo Co's PB Ratio or its related term are showing as below:
MEX:PRGON'
s PB Ratio Range Over the Past 10 Years
Min: 0.39 Med: 1.07 Max: 2.17
Current: 0.52
During the past 13 years, Perrigo Co's highest PB Ratio was 2.17. The lowest was 0.39. And the median was 1.07.
MEX:PRGON's PB Ratio is ranked better than 90.46% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.88
vs MEX:PRGON: 0.52
During the past 12 months, Perrigo Co's average Book Value Per Share Growth Rate was -43.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -16.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -10.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Perrigo Co was 58.00% per year. The lowest was -17.10% per year. And the median was 4.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Perrigo Co PB Ratio Related Terms
Perrigo Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Perrigo Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PRGON vs AMLX, HROW, ANIP: PB Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Perrigo Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Perrigo Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Perrigo Co (MEX:PRGON) has a PB Ratio of 1.71 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Perrigo Co and its competitors. This is 60% above median its historical median of 1.07. Over the past decade, Perrigo Co's PB Ratio has ranged from 0.39 to 2.17. According to the industry distribution chart, Perrigo Co ranks #88 out of 922 companies in the Drug Manufacturers industry, placing it in the top 9.5%.
Is Perrigo Co's PB Ratio too high?
Perrigo Co's current PB Ratio of 1.71 is 60% above median its 10-year median of 1.07. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 2.17. The Drug Manufacturers industry median PB Ratio is 1.88. Perrigo Co's value of 1.71 is 9% below this industry median. Based on the distribution chart, Perrigo Co ranks #88 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Perrigo Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's PB Ratio compare to AMLX and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #88 out of 922 companies for PB Ratio. This places Perrigo Co in the top 10% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.88. Perrigo Co's value of 1.71 is 9% below this benchmark. Historically, Perrigo Co's own PB Ratio has ranged from 0.39 to 2.17 over the past decade. While the company's 10-year median is 1.07 vs. the industry median of 1.88, Perrigo Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.88, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perrigo Co's current PB Ratio of 1.71 is 9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current PB Ratio is 1.71, which is 60% above median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current PB Ratio of 1.71. The stock's GF Value™ is MXN1,468.70, compared to a current price of MXN557.52 — trading 62% below its estimated fair value. The current PB Ratio is 1.71, which is 60% above median its 10-year median of 1.07 and 9% below the Drug Manufacturers industry median of 1.88. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current PB Ratio is 1.71 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (MEX:PRGON) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of MXN557.52 is trading 62% below its estimated GF Value™ of MXN1,468.70.
Key valuation signals for MEX:PRGON:
PB Ratio: 1.71 (60% above median its 10-year median of 1.07)
GF Value™: MXN1,468.70 vs. price of MXN557.52 (62% below fair value)
Industry Position: 9% below the Drug Manufacturers median (#88 of 922)
No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score
Get the complete analysis for MEX:PRGON
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PRGON has been successfully added to your 
